drugset / Trial / NCT03880448

Metronidazole vs Placebo as Adjuncts to Periodontal Surgery for Patients Positive to Porphyromonas Gingivalis

NCT03880448

Completed 17 enrolled Universidad Complutense de Madrid
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to determine whether the use of a systemic antimicrobial (metronidazole) as an adjunct to periodontal surgery provides additional clinical and microbiological beneficial effects compared to periodontal surgery alone plus a placebo, in patients with non treated periodontitis (stage III and IV) positive to Porphyromonas gingivalis.

Timeline

Start
2012-09-19
Primary completion
2018-01-15
Completion
2018-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 500 mg

Indications